UNSPSC 85782748: Alteration of right upper leg with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of right upper leg with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0Y0C47Z

UNSPSC 85782748 Alteration of right upper leg with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not reflect the actual work being solicited under it in state and local procurement. Recent opportunities tagged with this code involve independent medical evaluation services, occupational medical surveillance, pharmacy benefit management, surgical center-of-excellence programs, temporary health professional staffing, and emergency medical services for detained youth — none of which align with the surgical procedure named in the code itself. The code shows little relevant recent activity, and the mismatch between the nominal scope and the posted solicitations suggests either a tagging error or misclassification of opportunities by issuing bodies.

The geographic spread of recent activity spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (WSDOT), Florida (Collier County), and Texas (Harris County), with issuing bodies including city retirement offices, county human resources and health departments, state transportation agencies, and county juvenile probation departments. Representative opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 maximum over five years), Washington State Department of Transportation's RFQ for occupational medical surveillance services across 14 ferry locations (due October 9, 2026), and Collier County's RFP for pharmacy benefit management services (historical annual spending approximately $8.7 million). Given the systematic mismatch between code definition and posted work, this code does not present a reliable signal for business development targeting in this commodity area.